Christopher Baum
Impact in
Papers in
-
- CRISPR and Genetic Engineering 44
- RNA Interference and Gene Delivery 37
- Viral Infectious Diseases and Gene Expression in Insects 10
- Pluripotent Stem Cells Research 7
- Genetics 72
- Virus-based gene therapy research 69
- Co-authors
- Axel Schambach (38 shared papers)Ute Modlich (25 shared papers)Boris Fehse (14 shared papers)Zhixiong Li (16 shared papers)Melanie Galla (14 shared papers)Olga Kustikova (10 shared papers)Christof von Kalle (7 shared papers)Tobias Maetzig (9 shared papers)
- Journals
- Molecular Therapy (22 papers)Blood (18 papers)Human Gene Therapy (7 papers)Journal of Virology (5 papers)Experimental Hematology (4 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Christopher Baum
99 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 107
- Genetics 3.0k
- Virology 286
- Oncology 1.5k
- Molecular Biology 3.8k
- Hematology 418
Countries citing papers authored by Christopher Baum
This map shows the geographic impact of Christopher Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Baum more than expected).
Fields of papers citing papers by Christopher Baum
This network shows the impact of papers produced by Christopher Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Baum. The network helps show where Christopher Baum may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 335 | |
| 2 | 2006 | 308 | |
| 3 | 2005 | 284 | |
| 4 | 2006 | 268 | |
| 5 | 2008 | 225 | |
| 6 | 2011 | 214 | |
| 7 | 2004 | 186 | |
| 8 | 2008 | 156 | |
| 9 | 2003 | 156 | |
| 10 | 1999 | 133 | |
| 11 | 2013 | 131 | |
| 12 | 2003 | 125 | |
| 13 | 2008 | 125 | |
| 14 | 2003 | 124 | |
| 15 | 2007 | 117 | |
| 16 | 2011 | 114 | |
| 17 | 2007 | 109 | |
| 18 | 2007 | 106 | |
| 19 | 2006 | 94 | |
| 20 | 2007 | 79 |
About Christopher Baum
Christopher Baum is a scholar working on Molecular Biology, Genetics, Oncology, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 101 papers that have together received 5.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (69 papers), CRISPR and Genetic Engineering (44 papers), RNA Interference and Gene Delivery (37 papers), CAR-T cell therapy research (19 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers), Pluripotent Stem Cells Research (7 papers), Viral Infections and Immunology Research (6 papers) and HIV Research and Treatment (5 papers). The work is most often cited by research in Genetics (3.0k citations), Virology (286 citations), Oncology (1.5k citations), Molecular Biology (3.8k citations) and Hematology (418 citations). Christopher Baum has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Axel Schambach, Ute Modlich, Boris Fehse, Zhixiong Li, Melanie Galla, Olga Kustikova, Christof von Kalle, Tobias Maetzig, David A. Williams and Johann Meyer. Their work appears in journals such as Molecular Therapy, Blood, Human Gene Therapy, Journal of Virology and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.